DETROL LA Safety Information
DETROL LA capsules are once daily extended release capsules indicated for the treatment
of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
Important Safety Information
DETROL LA is contraindicated in patients with urinary retention, gastric retention,
or uncontrolled narrow-angle glaucoma and in patients who have demonstrated hypersensitivity
to the drug or its ingredients.
DETROL LA capsules should be used with caution in patients with clinically significant
bladder outflow obstruction, gastrointestinal obstructive disorders, controlled
narrow-angle glaucoma, and significantly reduced hepatic or renal function.
Dry mouth was the most frequently reported adverse event (DETROL LA 23% vs placebo
8%); others (≥4%) included headache (DETROL LA 6% vs placebo 4%), constipation (DETROL
LA 6% vs placebo 4%), and abdominal pain (DETROL LA 4% vs placebo 2%).
Download the
Full U.S. Prescribing and
Patient Information.